[Company Performance]: SKNB.F's stock price is significantly influenced by the company's financial health. Positive earnings reports, revenue growth, and strong profitability generally lead to increased investor confidence and a higher stock price. Conversely, losses or declining revenue can cause the stock price to fall.

[Industry Trends]: The overall performance of the biotechnology industry and the specific sector SKNB.F operates within impacts its stock price. Positive developments in biotechnology, new drug approvals in related fields, or favorable regulatory changes can boost investor sentiment and drive up the stock price. Negative industry news can have the opposite effect.

[Market Sentiment]: General market conditions and investor sentiment play a crucial role. A bullish market, where investors are optimistic, tends to lift stock prices across the board, including SKNB.F. Bearish markets, characterized by pessimism, can lead to widespread selling pressure and lower stock prices.

[Regulatory Environment]: Changes in regulations related to biotechnology, drug development, and healthcare can have a significant impact. Favorable regulatory decisions, such as easier approval pathways for new drugs, can boost the stock price. Unfavorable regulations can create uncertainty and negatively affect investor sentiment.

[Competition]: The competitive landscape affects SKNB.F's stock price. The emergence of new competitors or the success of existing competitors in developing similar products can reduce SKNB.F's market share and profitability, leading to a lower stock price. Conversely, SKNB.F's ability to innovate and maintain a competitive edge can drive its stock price higher.

[Economic Factors]: Macroeconomic factors, such as interest rates, inflation, and economic growth, can influence the stock market and, consequently, SKNB.F's stock price. Higher interest rates can make borrowing more expensive for companies, potentially slowing growth and affecting stock prices. Economic recessions can lead to lower consumer spending and reduced demand for healthcare products, negatively impacting SKNB.F.

[News and Events]: Company-specific news and events, such as clinical trial results, product launches, mergers and acquisitions, and management changes, can have a significant impact on the stock price. Positive news generally leads to a stock price increase, while negative news can cause the stock price to decline.

[Currency Fluctuations]: As a foreign stock, SKNB.F's price is affected by changes in currency exchange rates. A strengthening domestic currency (relative to the Euro, where SKNB.F is traded) can make the stock less attractive to international investors, potentially lowering the price. A weakening domestic currency can make the stock more attractive, potentially increasing the price.

[Investor Perception]: How investors perceive the company, its management, and its future prospects can influence the demand for the stock. Positive investor perception can drive up the stock price, while negative perception can lead to selling pressure and a lower stock price.

[Global Health Crises]: Events such as pandemics or other global health crises can heavily affect biotechnology companies. Increased demand for specific treatments or vaccines that the company develops can result in a large increase in the stock price. Conversely, health crises causing overall economic downturns might affect the financial stability and stock value.

[Political Stability]: Political instability or changes in government policies within the regions where SKNB.F operates can create uncertainty and affect investor confidence, potentially impacting the stock price.